Skip to main content
Clinical Trials/NCT03074708
NCT03074708UnknownNot Applicable

Zhujiang Hospital of the Southern Medical University

Zhujiang Hospital1 site in 1 country200 target enrollmentStarted: March 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
200
Locations
1
Primary Endpoint
operative time

Study Overview

Brief Summary

Background:The aim of the study is to value the application of three-dimensional visualization and three-dimensional printing in the hepatobiliary and pancreatic surgery.Method:From January 2016 to December 2018,the clinical data of 200 patients with the hepatobiliary and pancreatic diseases will be collected.All the patients received abdominal CT scanning and 3D reconstruction. Then we used the 3D reconstruction model and the 3D printed model based on the 3D reconstruction model in the operation planning and the operation.The clinical data include operative time, intraoperative blood loss,and postoperative complications after surgery.

Detailed Description

From January 2016 to December 2018,the clinical data of 200 patients with the hepatobiliary and pancreatic diseases will be collected.All the patients received abdominal CT scanning and 3D reconstruction. Then we used the 3D reconstruction model and the 3D printed model based on the 3D reconstruction model in the operation planning and the operation.The clinical data include operative time, intraoperative blood loss,and postoperative complications after surgery.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • the hepatobiliary and pancreatic diseases

Exclusion Criteria

  • none of the hepatobiliary and pancreatic diseases

Outcomes

Primary Outcomes

operative time

Time Frame: 1 year

operative time

Secondary Outcomes

  • postoperative complications after surgery(1 year)
  • intraoperative blood loss(1 year)

Investigators

Sponsor
Zhujiang Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Chihua Fang

Dr

Zhujiang Hospital

Study Sites (1)

Loading locations...

Similar Trials